Literature DB >> 7525576

Carboxyl terminus of inducible nitric oxide synthase. Contribution to NADPH binding and enzymatic activity.

Q W Xie1, H Cho, Y Kashiwabara, M Baum, J R Weidner, K Elliston, R Mumford, C Nathan.   

Abstract

Cloning of a nitric oxide synthase (NOS) from RAW 264.7 mouse macrophages (Xie, Q.-w., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., and Nathan, C. (1992) Science 256, 225-228) yielded two sets of cDNA: one with a longer coding region of 1144 amino acids, whose sequence matched that of the purified protein, and another with a shorter coding region of 1122 amino acids, in which the last 10 carboxyl-terminal amino acids differed completely from those of the long form. We have now found that the short form lacks NOS activity. To determine the basis of this defect, we prepared recombinant chimeric, deletional, and point mutants of the long and short NOS variants, monitored their expression by immunoblot, and tested their enzymatic activity. By itself, lack of the 22-carboxyl-terminal residues of the long form NOS was scarcely consequential. Mutation of Phe1122, the only aromatic residue within one of the longest conserved regions shared by all NOSs of reported sequence, reduced enzymatic activity by 41%. Deletion of 23 carboxyl-terminal amino acids (including Phe1122) reduced activity by 71%. Further loss of Ile1121, another completely conserved residue, reduced activity by 95%, and with the deletion of the rest of the conserved region, NOS activity was undetectable. Normal dimerization and binding of heme and calmodulin by the short variants militated against distortions of tertiary structure affecting the amino-terminal half or middle portion of the protein. In contrast, the short variants were deficient in binding to NADPH, as predicted by a model of tertiary structure based on that of spinach ferredoxin-NADP+ reductase. This is the first demonstration that the carboxyl terminus of NOS is a functionally critical region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525576

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Binding of CAP70 to inducible nitric oxide synthase and implications for the vectorial release of nitric oxide in polarized cells.

Authors:  Inmaculada Navarro-Lérida; Mónica Martínez-Moreno; Iván Ventoso; Alberto Alvarez-Barrientos; Ignacio Rodríguez-Crespo
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

2.  Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization.

Authors:  N T Eissa; J W Yuan; C M Haggerty; E K Choo; C D Palmer; J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

3.  Pioglitazone, PPARγ agonist, attenuates experimental autoimmune neuritis.

Authors:  Hhoonisha Ramkalawan; Yu-Zhong Wang; Ameet Hurbungs; Yan-Fang Yang; Fa-Fa Tian; Wen-Bin Zhou; Jing Li; Huan Yang; Bo Xiao; Wei Zhang
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  A leaf methanolic extract of Wercklea insignis attenuates the lipopolysaccharide-induced inflammatory response by blocking the NF-κB signaling pathway in RAW 264.7 macrophages.

Authors:  Ji-Won Park; Ok-Kyoung Kwon; Ha-young Jang; Hyeok Jeong; Sei-Ryang Oh; Hyeong-Kyu Lee; Sang-Bae Han; Kyung-Seop Ahn
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

6.  Complementation analysis of mutants of nitric oxide synthase reveals that the active site requires two hemes.

Authors:  Q W Xie; M Leung; M Fuortes; S Sassa; C Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  PCR-based gene targeting of the inducible nitric oxide synthase (NOS2) locus in murine ES cells, a new and more cost-effective approach.

Authors:  D A Randolph; J W Verbsky; L Yang; Y Fang; R Hakem; L E Fields
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

8.  Inducible nitric oxide synthase: identification of amino acid residues essential for dimerization and binding of tetrahydrobiopterin.

Authors:  H J Cho; E Martin; Q W Xie; S Sassa; C Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation.

Authors:  Jong-Heon Won; Ho-Taek Im; Yang-Hee Kim; Kyung-Jin Yun; Hee-Juhn Park; Jong-Won Choi; Kyung-Tae Lee
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

10.  Molecular and biochemical characterization of dNOS: a Drosophila Ca2+/calmodulin-dependent nitric oxide synthase.

Authors:  M Regulski; T Tully
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.